These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 7009140)

  • 21. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S
    Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral dissolving treatment of gallbladder calculi: focus in 1989].
    Erlinger S
    Ann Chir; 1989; 43(6):417-9. PubMed ID: 2817740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orally administered gallbladder therapeutic agents, Part 1: Chenix (chenodeoxycholic acid, CDCA).
    Wietlispach Claussen D
    Gastroenterol Nurs; 1993 Apr; 15(5):208-9. PubMed ID: 8485178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage.
    Walker S; Rudolph G; Raedsch R; Stiehl A
    Gastroenterology; 1992 Mar; 102(3):810-5. PubMed ID: 1537519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects.
    Northfield TC; LaRusso NF; Hofmann AF; Thistle JL
    Gut; 1975 Jan; 16(1):12-7. PubMed ID: 1140620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Internist therapy of cholelithiasis].
    Riemann JF
    Fortschr Med; 1981 May; 99(20):755-60. PubMed ID: 7262755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
    Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
    Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vivo dissolving of gall-stones: the effect of chenodeoxycholic acid. (author's transl)].
    Fromm H; Eschler A; Töllner D; Canzler H; Schmidt FW
    Dtsch Med Wochenschr; 1975 Aug; 100(32):1619-24. PubMed ID: 170051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occurrence of cholesterol monohydrate crystals in gallbladder and hepatic bile in man: influence of bile acid treatment.
    Sahlin S; Ahlberg J; Angelin B; Ewerth S; Nilsell K; Reihnér E; Einarsson K
    Eur J Clin Invest; 1988 Aug; 18(4):386-90. PubMed ID: 3139424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Feb; 27(2):95-131. PubMed ID: 6365507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The influence of chenodeoxycholic acid and ursodeoxycholic acid on the hepatic structure of the rat (author's transl)].
    Leuschner U; Schneider M; Korte L
    Z Gastroenterol; 1979 Apr; 17(4):244-55. PubMed ID: 433375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chenodeoxycholic Acid: An Update on Its Therapeutic Applications.
    Fiorucci S; Distrutti E
    Handb Exp Pharmacol; 2019; 256():265-282. PubMed ID: 31267167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison on Response and Dissolution Rates Between Ursodeoxycholic Acid Alone or in Combination With Chenodeoxycholic Acid for Gallstone Dissolution According to Stone Density on CT Scan: Strobe Compliant Observation Study.
    Lee JM; Hyun JJ; Choi IY; Yeom SK; Kim SY; Jung SW; Jung YK; Koo JS; Yim HJ; Lee HS; Lee SW; Kim CD
    Medicine (Baltimore); 2015 Dec; 94(50):e2037. PubMed ID: 26683912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical studies on dissolution of gallstones using ursodeoxycholic acid.
    Okumura M; Tanikawa K; Chúman Y; Kóji T; Nakagawa S; Nakamura Y; Iino H; Yamasaki S; Hisatsugu T
    Gastroenterol Jpn; 1977; 12(6):469-75. PubMed ID: 608570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.
    Xiao ZL; Biancani P; Carey MC; Behar J
    Hepatology; 2003 Jun; 37(6):1442-50. PubMed ID: 12774024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).
    Grundy SM; Lan SP; Lachin J
    J Clin Invest; 1984 Apr; 73(4):1156-66. PubMed ID: 6368591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A practical guide to the nonsurgical treatment of gallstones.
    Maudgal DP; Northfield TC
    Drugs; 1991 Feb; 41(2):185-92. PubMed ID: 1709849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.